| Product Name | NGAL ELISA kit (Human) |
|---|---|
| Description | This assay has high sensitivity and excellent specificity for detection of Neutrophil Gelatinase Associated Lipocalin (NGAL). No significant cross-reactivity or interference between Neutrophil Gelatinase Associated Lipocalin (NGAL) and analogues was observed. |
| Synonyms | Lipocalin-2; LCN2; p25; Lipocalin 2; Oncogene 24p3; 25 kDa alpha-2-microglobulin-related subunit of MMP-9; Siderocalin LCN2 |
| Method | Sandwich |
| Detection Range | 0.156-10ng/mL |
| Sensitivity | 0.065ng/mL |
| Target | NGAL |
| Specificity | This assay has high sensitivity and excellent specificity for detection of Neutrophil gelatinase-associated lipocalin (NGAL). No significant cross-reactivity or interference between Neutrophil gelatinase-associated lipocalin (NGAL) and analogues was observed. |
| Reactivity | Human |
| Sample Types | Serum, Plasma, Urine, Tissue Homogenates, Cell Lysates, Cell Culture Supernates And Other Biological Fluids |
| Reconstitution | 1.Prepare all reagents, samples and standards; 2.Add 100uL standard or sample to each well.Incubate 2 hours at 37℃; 3.Aspirate and add 100uL prepared Detection Reagent A.Incubate 1 hour at 37℃; 4.Aspirate and wash 3 times; 5.Add 100uL prepared Detection Reagent B.Incubate 30 minutes at 37℃; 6.Aspirate and wash 5 times; 7.Add 90uL Substrate Solution.Incubate 10-20 minutes at 37℃; 8.Add 50uL Stop Solution.Read at 450nm immediately. |
| Uniprot | P80188 |
| Storage | 4°C for 1 month/ -20°C for long-term(within shelf life) |
| Notes | Colormetric |
| References | Correlation of serum neutrophil gelatinase-associated lipocalin with acute kidney injury in hypertensive disorders of pregnancy;Cholesterol Contributes to Diabetic Nephropathy through SCAP-SREBP-2 Pathway;Lipocalin-2: Response To Resistance Training in Obese Young Men;Effects of Resistance versus Endurance Training on Plasma Lipocalin-2 in Young Men;Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap;NGAL ;Hs-CRP and Adipokin (Lcn2): Response to Exercise Training in Obese Men;A Study On Thyroid Hormone And Its Effects On Exercise ;、118 ;Correlation of serum neutrophil gelatinase associated lipocalin with disease severity in hypertensive disorders of pregnancy;Increased serum levels of lipocalin-1 and-2 in patients with stable chronic obstructive pulmonary disease;Increased cardiac index attenuates septic acute kidney injury: a prospective observational study;;From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases.;Diabetes-induced renal failure is associated with tissue inflammation and neutrophil gelatinase-associated lipocalin: Effects of resveratrol;Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis.;Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN);From varices to venous ulceration: the story of chronic venous disease described by metalloproteinases;Hemojuvelin Predicts Acute Kidney Injury and Poor Outcomes Following Cardiac Surgery;Chronic obstructive pulmonary disease (COPD)--from biomarkers to clinical phenotypes;Potential Novel Biomarkers of Obstructive Nephropathy in Children with Hydronephrosis;The Kidney Specific Protein myo-Inositol Oxygenase, a Potential Biomarker for Diabetic Nephropathy;The evaluation of acute kidney injury due to ischemia by urinary neutrophil gelatinase-induced lipocalin (uNGAL) measurement in patients who underwent partial …;CОСТОЯНИЕ ТИРЕОИДНОЙ ФУНКЦИИ У ПАЦИЕНТОВ С САХАРНЫМ ДИАБЕТОМ 1-ГО ТИПА И ХРОНИЧЕСКОЙ БОЛЕЗНЬЮ ПОЧЕК …;Thyroid function in patients with type 1 diabetes mellitus and chronic kidney disease receiving renal replacement therapy;Early Kidney Injury in Immunoglobulin A Vasculitis: Role of Renal Biomarkers;Elevated plasma level of neutrophil gelatinase-associated lipocalin (NGAL) in patients with breast cancer; |
| Supplier | Cloud Clone |
PROTOCOLS:
SEB388Hu All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.
